ThermoGenesis Corp. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	31
ISBN Number	not applicable
Product Code	GMD04806

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a ThermoGenesis Corp.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Overview
- 2.1 Key Information
- 2.2 Industry Outlook Hospital Supplies
3 Major Products and Services
- 3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
- 6.1 Head Office
7 Recent Developments
- 7.1 Financial Announcements
  - 7.1.1 May 07, 2008: ThermoGenesis Reports Q3 Fiscal 2008 Results
- 7.2 Corporate Communications
  - 7.2.1 Aug 06, 2008: ThermoGenesis Appoints New Board Member
  - 7.2.2 Mar 12, 2008: ThermoGenesis Appoints Board Member
- 7.3 Product News
  - 7.3.1 May 26, 2005: ThermoGenesis Autologous Thrombin Processing Device (TPD) Receives CE Mark to Allow Sales in Europe
  - 7.3.2 Jan 26, 2005: ThermoGenesis' Cryoseal Fibrin Sealant Reduces Blood Loss And Pain In Total Knee Arthroplasty (TKA) Study
- 7.4 Product Approvals
  - 7.4.1 May 26, 2005: ThermoGenesis Autologous Thrombin Processing Device (TPD) Receives CE Mark to Allow Sales in Europe
- 7.5 Clinical Trials
  - 7.5.1 Jan 26, 2005: ThermoGenesis' Cryoseal Fibrin Sealant Reduces Blood Loss And Pain In Total Knee Arthroplasty (TKA) Study
8 ThermoGenesis Corp. Pipeline Products
- 8.1 ThermoGenesis Corp. Product Pipeline Analysis
  - 8.1.1 ThermoGenesis Corp. Pipeline Products By Equipment Type
  - 8.1.2 ThermoGenesis Corp. Pipeline Products By Development Stage
  - 8.1.3 ThermoGenesis Corp. Pipeline Products By Therapy Area
  - 8.1.4 ThermoGenesis Corp. Pipeline Products By Clinical Trials
  - 8.1.5 ThermoGenesis Corp. Pipeline Products By News Summary
- 8.2 CryoSeal Fibrin Sealant System
  - 8.2.1 Product Description
  - 8.2.2 Product Status
  - 8.2.3 Clinical Trials
  - 8.2.4 Product Milestone
  - 8.2.5 Product Patent Details
- 8.3 TPD Thrombin Processing Device
  - 8.3.1 Product Description
  - 8.3.2 Product Status
  - 8.3.3 Product Milestone
- 8.4 CryoSeal Fibrin Sealant System-Dermal Wounds
  - 8.4.1 Product Description
  - 8.4.2 Product Status
  - 8.4.3 Product Patent Details
- 8.5 CryoSeal Fibrin Sealant System-ENT
  - 8.5.1 Product Description
  - 8.5.2 Product Status
  - 8.5.3 Product Patent Details
- 8.6 CryoSeal Fibrin Sealant System-Ortho
  - 8.6.1 Product Description
  - 8.6.2 Product Status
  - 8.6.3 Clinical Trials
9 Appendix
- 9.1 Methodology
  - 9.1.1 Coverage
  - 9.1.2 Secondary Research
  - 9.1.3 Primary Research
  - 9.1.4 Expert Panel Validation
- 9.2 Contact Us
- 9.3 About Global Markets Direct
- 9.4 Disclaimer
1 List of Tables
- Table 1: ThermoGenesis Corp.,Key Facts
- Table 2: ThermoGenesis Corp., Key Employees,
- Table 3: ThermoGenesis Corp. Pipeline Products by Equipment Type
- Table 4: ThermoGenesis Corp. Pipeline Products By Development Stage
- Table 5: ThermoGenesis Corp. Pipeline Products By Therapy Area
- Table 6: ThermoGenesis Corp. Pipeline Products By Clinical Trials
- Table 7: ThermoGenesis Corp. Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: ThermoGenesis Corp. Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology